Competitive Problems in the Drug Industry: Psychotropic Drugs : Summary and Analysis |
Contents
Letter of submittal_ | 1 |
Health benefits of psychotropic drugs | 16 |
Public policy and psychotropic drugs | 34 |
1 other sections not shown
Other editions - View all
Common terms and phrases
action active ingredients advertising Advisory Review Panel amine aminoxide hydrobromide analgesic antihista antihistamines bromide Bromism caffeine carcinogen chloride claims cludes coffee Combinations containing Commissioner concludes compounds consumer diphenhydramine dosage levels doses doxylamine succinate drowsiness Drug Products Evaluation fectiveness Federal Food and Drug histamine hypnotic Ibid ingestion Journal labeling Lijinsky liver lucanthone ment methapyrilene methapyrilene hydrochloride mg/kg monograph ness nitrite nitrosamine nitrosation oral OTC daytime sedatives OTC mood drugs OTC night OTC nighttime sleep-aid OTC products OTC stimulants OTC Volume Panel on OTC patients pentobarbital percent Pharmacology phenyltoloxamine physician placebo placed in Category problem products containing PROPOSED RULES psychotropic drugs Psychotropic Drugs Hearings pyrilamine rats recognized as safe recommended safe and effective safety salicylamide scopol scopolamine scopolamine aminoxide secobarbital seda sedation side effects sioner sleeplessness symptoms Tablets tardive dyskinesia target population testing therapeutic tients tion tive toxic tumors vitamins warning